ADME Study of [14C]- Larotinib in Healthy Male Subjects

NCT05059743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male Volunteers

Interventions

DRUG: [14C]-Larotinib

Sponsor

Sunshine Lake Pharma Co., Ltd.